We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As of Aug. 31, there had been at least 66 infections, including 60 bloodstream infections, associated with these affected products, the agency said. Read More
The device was deigned to “optimize fusion, while maintaining elasticity that is similar to bone and radiolucency of the cage body,” the company said. Read More
“We believe in the value of science behind Eliquis and its therapeutic potential for patients, and the underlying intellectual property protecting these innovations,” the companies said in a joint statement. Read More
The company is developing permanently implanted stimulation electrodes for patients with chronic conditions, such as epilepsy, Parkinson's disease and chronic back pain. Read More
An estimated 8,000 UK citizens suffering from hormone-sensitive or hormone-relapsed prostate cancer will now be eligible to receive treatment. Read More
The neurostimulation device increases tissue oxygenation by 28 percent and decreases pressure-induced tissue damage by 80 percent, the company said. Read More